Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coenzyme Q biosynthesis protein 4 homolog, mitochondrial (COQ4) is a non-enzymatic scaffold protein essential for the biosynthesis of coenzyme Q (ubiquinone) in the mitochondrial inner membrane. COQ4 organizes and stabilizes the multi-protein complex responsible for coenzyme Q production, indirectly supporting mitochondrial oxidative phosphorylation, cellular energy generation, and antioxidant protection. Mutations in COQ4 cause primary coenzyme Q10 deficiency, a rare mitochondrial disease that can result in neurological, muscular, and renal symptoms due to impaired energy metabolism and increased vulnerability to oxidative stress. COQ4 is a therapeutic target in the sense that its dysfunction leads to disease states treatable by ubiquinone supplementation, though it is not amenable to classical drug targeting as an enzyme or receptor.
Drugs (supplements) substitute for deficient coenzyme Q in mitochondrial electron transport and antioxidant defense; this is replacement therapy, not inhibition/activation of COQ4 itself
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coenzyme Q biosynthesis protein 4 homolog, mitochondrial (COQ4).